Latest Breaking News On - Astellas pharma - Page 1 : comparemela.com

FDA Acknowledges Astellas Pharma s Resubmission Of BLA For Zolbetuximab

TOKYO (dpa-AFX) - The U.S. Food and Drug Administration has acknowledged Astellas Pharma's resubmission of the Biologics License Application (BLA) for zolbetuximab, a first-in-class investigational

Astellas pharmaMore such health newsDrug administrationBiologics license applicationPrescription drug user fee actIhr portfolio

U S Food and Drug Administration Acknowledges Astellas Pharma Inc ? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration has acknowledged the company s resubmission of the Biologics License Application for zolbetuximab, a first-in-class.

United kingdomUnited statesJapan ministry of healthDrug administrationAstellas pharma incAstellas pharmaBiologics license applicationPrescription drug user fee actSouth america

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes
neurologyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neurologyadvisor.com Daily Mail and Mail on Sunday newspapers.

Angelica lindKarolinska institutetAstellas pharmaEuropean society of endocrinologyEuropean congressHealthday newsEuropean society

FDA Accepts BLA Resubmission for Zolbetuximab in CLDN18 2+ Advanced Gastric/GEJ Adenocarcinoma

FDA Accepts BLA Resubmission for Zolbetuximab in CLDN18 2+ Advanced Gastric/GEJ Adenocarcinoma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesMoitreyee chatterjee kishoreAstellas pharmaOncology development at astellasPrescription drug user fee actImmuno oncology development

Nanoform s biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

Nanoform s biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned
di.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from di.se Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiBluepharma farmaceuticaJeanne thomaChristian jonesBiologics poAndreas liebmingerAstellas pharma europeNanoform finland plcCo ltdJohnson janssen biotech incBoard of directors nanoform finland plcFinland branchGlobal head of therapies pharmaceutical sciencesConsortium bluepharmaCertified adviser to nanoform finland plc